Ameloblastoma medical therapy: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(15 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Ameloblastoma}}
{{Ameloblastoma}}
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}; {{AE}}{{Simrat}}
==Overview==
==Overview==
The mainstay of therapy for ameloblastoma is surgery. The predominant therapy for ameloblastoma is surgical resection. Adjunctive chemotherapy/radiation/chemoradiation may be required.
The mainstay of therapy for ameloblastoma is [[surgery]]. Adjunctive [[chemotherapy]]/[[radiation]]/chemoradiation may be required.


==Medical Therapy==
==Medical Therapy==
* The mainstay of therapy for ameloblastoma is [[surgical resection]] or [[enucleation]].<ref name="McClaryWest2015">{{cite journal|last1=McClary|first1=Andrew C.|last2=West|first2=Robert B.|last3=McClary|first3=Ashley C.|last4=Pollack|first4=Jonathan R.|last5=Fischbein|first5=Nancy J.|last6=Holsinger|first6=Christopher F.|last7=Sunwoo|first7=John|last8=Colevas|first8=A. Dimitrios|last9=Sirjani|first9=Davud|title=Ameloblastoma: a clinical review and trends in management|journal=European Archives of Oto-Rhino-Laryngology|volume=273|issue=7|year=2015|pages=1649–1661|issn=0937-4477|doi=10.1007/s00405-015-3631-8}}</ref><ref name="pmid29682361">{{cite journal |vauthors=Aramanadka C, Kamath AT, Kudva A |title=Recurrent Ameloblastoma: A Surgical Challenge |journal=Case Rep Dent |volume=2018 |issue= |pages=8271205 |date=2018 |pmid=29682361 |pmc=5841118 |doi=10.1155/2018/8271205 |url=}}</ref><ref name="VirmaniDabholkar2016">{{cite journal|last1=Virmani|first1=Nitish|last2=Dabholkar|first2=Jyoti|title=Giant multiloculated ameloblastoma of the mandible: a case report and review of literature|journal=International Journal of Otorhinolaryngology and Head and Neck Surgery|volume=2|issue=2|year=2016|pages=91|issn=2454-5937|doi=10.18203/issn.2454-5929.ijohns20160962}}</ref>


Management of ameloblastoma has been controversial because of the unique biological behavior of this disease as a slow-growing, locally invasive tumor with a high rate of recurrence.[12–17] Recurrence rates of ameloblastoma are reportedly as high as 15-25% after radical treatment[13–15] and 75-90% after conservative treatment.[13–17] Therefore, wide resection of the jaw in accordance with the treatment of malignant tumors is usually recommended for ameloblastomas. Recent advancements in understanding the biological behaviors of ameloblastoma have led to more rational surgical app
* Patients with ameloblastoma are treated with [[chemotherapy]], radiation and chemoradiation.
Treatment of mandibular ameloblastoma continues to be
* Patients with ameloblastoma are also treated with [[curettage]] and liquid nitrogen have been effective in some cases.
controversial. It can change with clinicoradiologic variant,
anatomic location and clinical behaviour of the tumour.5
Also, the age and the general state of health of the patient
are important factors. Treatment consists of wide resection,
curettage and enucleation.6,10 Rates of recurrence may be as
high as 15% to 25% after radical treatment and 75% to
90% after conservative treatment.10 The aim of this article
is to describe conservative treatment of ameloblastoma by
enucleation and bone curettage in cases where the lower
border of the mandible is not affected by the tumour.
Management of ameloblastoma has been controversial because of the unique biological behavior of this disease as a slow-growing, locally invasive tumor with a high rate of recurrence.[12–17] Recurrence rates of ameloblastoma are reportedly as high as 15-25% after radical treatment[13–15] and 75-90% after conservative treatment.[13–17] Therefore, wide resection of the jaw in accordance with the treatment of malignant tumors is usually recommended for ameloblastomas. Recent advancements in understanding the biological behaviors of ameloblastoma have led to more rational surgical app
 
Treatment modalities are dictated by size [4, 5], anatomical location (Table 1) [6], histologic variant, and anatomical involvement [7]. On the one hand, there is a school advocating major segmental or en bloc resection for ameloblastoma with a requirement of 1–1.5 cm of clinically and radiographically normal bone and uninvolved margins. On the other hand, there is a school advocating a more conservative surgical management by enucleation with adjacent bone
 
 
 
 
 
*Surgery is the most common treatment of this tumor. Excision of normal tissue near the tumor margin is often required, because of the invasive nature of the growth. ameloblastoma has tendency to spread to adjacent bony and sometimes soft tissues without metastasizing.
*Although ameloblastoma is not a cancer that actually invades adjacent tissues, it is suspected to spread to adjacent areas of the jaw bone via marrow space. Thus, wide surgical margins that are clear of disease are required for a good prognosis. This is very much like surgical treatment of cancer.
*Often, treatment requires excision of entire portions of the jaw. Surgery is the only effective method for removing the excess tissue growth. A wide surgical excision is often required; in majority of cases, a part of the bone beneath the growth must be removed as well. Surgical curettage of the bone tumor is another treatment modality- although, there is a higher chance of recurrence with this treatment method.
*Since, surgery is a highly effective method to treat ameloblastoma, in most situations, chemotherapy and radiation treatment is not preferred. Facial reconstructive surgeries may be required, after removal of the tumor. Radiation is ineffective in many cases of ameloblastoma. There have also been reports of sarcoma being induced as the result of using radiation to treat ameloblastoma. Chemotherapy is also often ineffective. However, there is some controversy regarding this and some indication that some ameloblastomas might be more responsive to radiation that previously thought.


==References==
==References==
Line 39: Line 18:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Otolaryngology]]

Latest revision as of 18:57, 23 October 2019

Ameloblastoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ameloblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ameloblastoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ameloblastoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ameloblastoma medical therapy

CDC on Ameloblastoma medical therapy

Ameloblastoma medical therapy in the news

Blogs on Ameloblastoma medical therapy

Directions to Hospitals Treating Ameloblastoma

Risk calculators and risk factors for Ameloblastoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

The mainstay of therapy for ameloblastoma is surgery. Adjunctive chemotherapy/radiation/chemoradiation may be required.

Medical Therapy

  • Patients with ameloblastoma are treated with chemotherapy, radiation and chemoradiation.
  • Patients with ameloblastoma are also treated with curettage and liquid nitrogen have been effective in some cases.

References

  1. ↑ McClary, Andrew C.; West, Robert B.; McClary, Ashley C.; Pollack, Jonathan R.; Fischbein, Nancy J.; Holsinger, Christopher F.; Sunwoo, John; Colevas, A. Dimitrios; Sirjani, Davud (2015). "Ameloblastoma: a clinical review and trends in management". European Archives of Oto-Rhino-Laryngology. 273 (7): 1649–1661. doi:10.1007/s00405-015-3631-8. ISSN 0937-4477.
  2. ↑ Aramanadka C, Kamath AT, Kudva A (2018). "Recurrent Ameloblastoma: A Surgical Challenge". Case Rep Dent. 2018: 8271205. doi:10.1155/2018/8271205. PMC 5841118. PMID 29682361.
  3. ↑ Virmani, Nitish; Dabholkar, Jyoti (2016). "Giant multiloculated ameloblastoma of the mandible: a case report and review of literature". International Journal of Otorhinolaryngology and Head and Neck Surgery. 2 (2): 91. doi:10.18203/issn.2454-5929.ijohns20160962. ISSN 2454-5937.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Ameloblastoma_medical_therapy&oldid=1585461"